Ramakrishnan Ajay Kumar (R Ajay Kumar)

Years Active: 2020-2022
Publications (10 Years): 5

Rajiv Gandhi Centre for Biotechnology

Rajiv Gandhi Centre for Biotechnology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rajiv Gandhi Centre for Biotechnology

India

Scientist :: Mycobacterium Research Group

Education History

Rajiv Gandhi Centre for Biotechnology

India

PHD :: Mycobacterium Research Group

Publications

Akhil Raj Pushparajan, Lekshmi K Edison, Ramakrishnan Ajay Kumar
Mycobacterium tuberculosis transcriptional regulator Rv1019 is upregulated in hypoxia, and negatively regulates Rv3230c-Rv3229c operon encoding enzymes in the oleic acid biosynthetic pathway. The FEBS journal (2022)
S Salini, Sinchana G Bhat, Saba Naz, Ramanathan Natesh, Ramakrishnan Ajay Kumar, Vinay Kumar Nandicoori, Krishna Kurthkoti
The Error-Prone Polymerase DnaE2 Mediates the Evolution of Antibiotic Resistance in Persister Mycobacterial Cells. Antimicrobial agents and chemotherapy 66 (3) (2022)
Aravind Madhavan, K B Arun, Akhil Raj Pushparajan, M Balaji, Ramakrishnan Ajay Kumar
Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy. mSphere 6 (1) (2021)
Akhil Raj Pushparajan, Ranjit Ramachandran, Jijimole Gopi Reji, Ramakrishnan Ajay Kumar
Mycobacterium tuberculosis TetR family transcriptional regulator Rv1019 is a negative regulator of the mfd-mazG operon encoding DNA repair proteins. FEBS letters 594 (17) (2020)
Arun Karthika Bahuleyan, Aravind Madhavan, Billu Abraham, M Balaji, K C Sivakumar, P Nisha, Ramakrishnan Ajay Kumar
Acetylation of Isoniazid Is a Novel Mechanism of Isoniazid Resistance in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 65 (1) (2020)

Ramakrishnan Ajay Kumar.css-eqlu8i{font-size:small;padding-left:4px;} (R Ajay Kumar)